These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 27404565)

  • 1. Oxidative Stress Induced by Pt(IV) Pro-drugs Based on the Cisplatin Scaffold and Indole Carboxylic Acids in Axial Position.
    Tolan D; Gandin V; Morrison L; El-Nahas A; Marzano C; Montagner D; Erxleben A
    Sci Rep; 2016 Jul; 6():29367. PubMed ID: 27404565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multi-Acting Mitochondria-Targeted Platinum(IV) Prodrugs of Kiteplatin with α-Lipoic Acid in the Axial Positions.
    Savino S; Marzano C; Gandin V; Hoeschele JD; Natile G; Margiotta N
    Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30011897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pt(IV) pro-drugs with an axial HDAC inhibitor demonstrate multimodal mechanisms involving DNA damage and apoptosis independent of cisplatin resistance in A2780/A2780cis cells.
    Almotairy ARZ; Montagner D; Morrison L; Devereux M; Howe O; Erxleben A
    J Inorg Biochem; 2020 Sep; 210():111125. PubMed ID: 32521289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular trafficking, accumulation and DNA platination of a series of cisplatin-based dicarboxylato Pt(IV) prodrugs.
    Ravera M; Gabano E; Zanellato I; Bonarrigo I; Alessio M; Arnesano F; Galliani A; Natile G; Osella D
    J Inorg Biochem; 2015 Sep; 150():1-8. PubMed ID: 26042542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiaction Pt(IV) Complexes: Cytotoxicity in Ovarian Cancer Cell Lines and Mechanistic Studies.
    Tabrizi L; M Jones A; Romero-Canelon I; Erxleben A
    Inorg Chem; 2024 Aug; 63(32):14958-14968. PubMed ID: 39083592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platinum(IV)-nitroxyl complexes as possible candidates to circumvent cisplatin resistance in RT112 bladder cancer cells.
    Cetraz M; Sen V; Schoch S; Streule K; Golubev V; Hartwig A; Köberle B
    Arch Toxicol; 2017 Feb; 91(2):785-797. PubMed ID: 27307157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel Pt(IV) Prodrugs Displaying Antimitochondrial Effects.
    Tabrizi L; Thompson K; Mnich K; Chintha C; Gorman AM; Morrison L; Luessing J; Lowndes NF; Dockery P; Samali A; Erxleben A
    Mol Pharm; 2020 Aug; 17(8):3009-3023. PubMed ID: 32628022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and characterization of Pt(IV) fluorescein conjugates to investigate Pt(IV) intracellular transformations.
    Song Y; Suntharalingam K; Yeung JS; Royzen M; Lippard SJ
    Bioconjug Chem; 2013 Oct; 24(10):1733-40. PubMed ID: 23957697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complexes of oxoplatin with rhein and ferulic acid ligands as platinum(iv) prodrugs with high anti-tumor activity.
    Tan MX; Wang ZF; Qin QP; Zou BQ; Liang H
    Dalton Trans; 2020 Feb; 49(5):1613-1619. PubMed ID: 31942585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting ROS-AMPK pathway by multiaction Platinum(IV) prodrugs containing hypolipidemic drug bezafibrate.
    Qiao X; Gao YY; Zheng LX; Ding XJ; Xu LW; Hu JJ; Gao WZ; Xu JY
    Eur J Med Chem; 2021 Nov; 223():113730. PubMed ID: 34388483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effective platinum(IV) prodrugs conjugated with lonidamine as a functional group working on the mitochondria.
    Chen H; Chen F; Hu W; Gou S
    J Inorg Biochem; 2018 Mar; 180():119-128. PubMed ID: 29253663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stability, Reduction, and Cytotoxicity of Platinum(IV) Anticancer Prodrugs Bearing Carbamate Axial Ligands: Comparison with Their Carboxylate Analogues.
    Chen S; Yao H; Zhou Q; Tse MK; Gunawan YF; Zhu G
    Inorg Chem; 2020 Aug; 59(16):11676-11687. PubMed ID: 32799457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiaction Pt(IV) Carbamate Complexes Can Codeliver Pt(II) Drugs and Amine Containing Bioactive Molecules.
    Babu T; Sarkar A; Karmakar S; Schmidt C; Gibson D
    Inorg Chem; 2020 Apr; 59(7):5182-5193. PubMed ID: 32207294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving of Anticancer Activity and Solubility of Cisplatin by Methylglycine and Methyl Amine Ligands Against Human Breast Adenocarcinoma Cell Line.
    Shams Abyaneh FS; Eslami Moghadam M; Divsalar A; Ajloo D; Hosaini Sadr M
    Appl Biochem Biotechnol; 2018 Oct; 186(2):271-291. PubMed ID: 29516403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic and antitumor effects of platinum(IV)-octanoato conjugates.
    Novohradsky V; Zanellato I; Marzano C; Pracharova J; Kasparkova J; Gibson D; Gandin V; Osella D; Brabec V
    Sci Rep; 2017 Jun; 7(1):3751. PubMed ID: 28623355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual-acting antitumor Pt(iv) prodrugs of kiteplatin with dichloroacetate axial ligands.
    Savino S; Gandin V; Hoeschele JD; Marzano C; Natile G; Margiotta N
    Dalton Trans; 2018 May; 47(21):7144-7158. PubMed ID: 29766157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological activity of a series of cisplatin-based aliphatic bis(carboxylato) Pt(IV) prodrugs: how long the organic chain should be?
    Zanellato I; Bonarrigo I; Colangelo D; Gabano E; Ravera M; Alessio M; Osella D
    J Inorg Biochem; 2014 Nov; 140():219-27. PubMed ID: 25171667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytotoxicity and cellular response mechanisms of water-soluble platinum(II) complexes of lidocaine and phenylcyanamide derivatives.
    Tabrizi L; Chiniforoshan H
    Biometals; 2017 Feb; 30(1):59-70. PubMed ID: 27995355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cisplatin-based Pt(iv)-diclorofibrato multi-action anticancer prodrug exhibits excellent performances also under hypoxic conditions.
    Gabano E; Ravera M; Trivero F; Tinello S; Gallina A; Zanellato I; Gariboldi MB; Monti E; Osella D
    Dalton Trans; 2018 Jun; 47(25):8268-8282. PubMed ID: 29892758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platinum(II) carboxylato complexes containing 7-azaindoles as N-donor carrier ligands showed cytotoxicity against cancer cell lines.
    Štarha P; Trávníček Z; Pazderová L; Dvořák Z
    J Inorg Biochem; 2016 Sep; 162():109-116. PubMed ID: 27350081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.